Catalyst Funds Management Pty LTD Citius Pharmaceuticals, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 27,200 shares of CTXR stock, worth $10,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,200Holding current value
$10,608% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
67Shares Held
30.1MCall Options Held
24.7KPut Options Held
0-
Armistice Capital, LLC New York, NY7.28MShares$2.84 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$2.51 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$732,7910.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$704,2330.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$451,8180.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $57M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...